Synthekine Reports Updated Clinical and Translational Findings for STK-012 in First-Line Non-Squamous NSCLC at AACR 2026 Synthekine, a clinical-stage biotechnology company focused on precision cytokine therapeutics, has released updated clinical…
HCA Healthcare Lands 29 Hospitals on Modern Healthcare’s Top 100 List HCA Healthcare has announced that 29 of its hospitals have earned recognition as top-performing facilities in the 2026 edition…
Synthetic Design Lab Debuts First Logic-Gated ADC at AACR 2026, Showing Over 10X Boost in Cancer Cell Killing Synthetic Design Lab has unveiled a bold new direction in the field…
Lundbeck Shares AAN 2026 Data Showing Real-World Cognitive Improvements in Migraine Patients Treated with VYEPTI Lundbeck today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology…
Definium Therapeutics Supports White House Order to Advance Psychedelic Mental Health Treatments Definium Therapeutics a late-stage clinical biopharmaceutical company focused on addressing the root causes of psychiatric and neurological disorders,…
Compass Pathways Backs White House Initiative to Accelerate Psychedelic Treatments for Mental Health Compass Pathways plc a biotechnology company focused on expanding access to evidence-based mental health innovations, has expressed…
SurGenTec Wins FDA 510(k) Clearance for TiLink™ SI Joint Fusion System with Navigation Compatibility SurGenTec, LLC, a company recognized for its innovation in spine and orthopedic technologies, has announced that…
A Milestone for Keratoconus Treatment Glaukos Corporation has announced a significant regulatory and reimbursement milestone for its innovative therapy, Epioxa™ (Epioxa HD / Epioxa), designed to treat Keratoconus—a progressive and…
Covalon Technologies Demonstrates Strong Momentum Across Key Healthcare Segments Covalon Technologies Ltd., a leader in advanced medical technologies, has announced a series of notable milestones that underscore its accelerating commercial…
AACR 2026: STC-1010 Shows Safety & Early Immune Activity in MSS CRC Brenus Pharma, a clinical-stage biotechnology company based in Lyon, France, has announced the presentation of new first-in-human data…
Johnson & Johnson Showcases Strong Clinical Evidence for TECNIS PureSee™ IOL at ASCRS 2026 At the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting held in Washington,…
AI Clinical Trial Matching Study in 3,804 Cancer Patients by Massive Bio Massive Bio, a global precision oncology company, has announced the publication of a major prospective study demonstrating the…